⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6685872 | 1.00 | — | — | |
| SCHEMBL8733766 | 0.84 | — | — | |
| SCHEMBL14137725 | 0.72 | — | — | |
| SCHEMBL14480508 | 0.65 | — | — | |
| SCHEMBL5710534 | 0.63 | — | — | |
| SCHEMBL4784620 | 0.61 | — | — | |
| SCHEMBL17239392 | 0.60 | NOS3 (0.30) | — | |
| SCHEMBL17239391 | 0.60 | NOS3 (0.30) | — | |
| SCHEMBL19621655 | 0.59 | — | — | |
| SCHEMBL8205685 | 0.59 | ALDH1A1 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3071591-A2 | ANTIMICROBIAL PEPTIDOMIMETICS | Agency For Science, Technology And Research (SG) | 2016-09-28 | — | — | EP | claimed |
| WO-2015112093-A2 | ANTIMICROBIAL PEPTIDOMIMETICS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-07-30 | — | — | WO | claimed |
| EP-1303527-A1 | MATRIX METALLOPROTEINASE INHIBITORS | Leo Pharma A/S (DK) | 2003-04-23 | — | — | EP | claimed |
| WO-2002006293-A1 | MATRIX METALLOPROTEINASE INHIBITORS | LEO PHARMA A/S (DK) | 2002-01-24 | — | — | WO | claimed |
| WO-2013096093-A1 | COMPOUNDS AS DGAT-1 INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2013-06-27 | — | — | WO | disclosed |
| EP-2384321-A1 | PYRIMIDINE DERIVATIVES AND THE USE THEREOF FOR COMBATING UNDESIRED PLANT GROWTH | Bayer CropScience AG (DE) | 2011-11-09 | — | — | EP | disclosed |
| EP-2307378-A1 | NICOTINAMIDE DERIVATIVES | Pfizer Limited (GB) | 2011-04-13 | — | — | EP | disclosed |
| EP-2301091-A1 | CYCLIC PHOSPHAZENE COMPOUNDS AND USE THEREOF IN ORGANIC LIGHT EMITTING DIODES | BASF SE (DE) | 2011-03-30 | — | — | EP | disclosed |
| WO-2010076010-A1 | PYRIMIDINE DERIVATIVES AND THE USE THEREOF FOR COMBATING UNDESIRED PLANT GROWTH | BAYER CROPSCIENCE AG (DE) | 2010-07-08 | — | — | WO | disclosed |
| WO-2009153276-A1 | CYCLIC PHOSPHAZENE COMPOUNDS AND USE THEREOF IN ORGANIC LIGHT EMITTING DIODES | BASF SE (DE) | 2009-12-23 | — | — | WO | disclosed |
| WO-2009153721-A1 | NICOTINAMIDE DERIVATIVES | PFIZER LIMITED (GB) | 2009-12-23 | — | — | WO | disclosed |
| WO-2008130319-A2 | NOVEL N-TETRAHYDRONAPHTALENE OR N-CHROMANE CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN | ASTRAZENECA AB (SE) | 2008-10-30 | — | — | WO | disclosed |
| EP-1341786-A1 | SUBSTITUTED DERIVATIVES OF AMINOFURAN-2-YL-ACETIC ACID AND AMINOTHIEN-2-YL-ACETIC ACID AND THE USE THEREOF FOR TREATING MIGRAINES AND PAIN | Grünenthal GmbH (DE) | 2003-09-10 | — | — | EP | disclosed |
| WO-2003045912-A1 | INHIBITORS OF FACTOR XA AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE | WARNER-LAMBERT COMPANY LLC (US) | 2003-06-05 | — | — | WO | disclosed |
| WO-2003040096-A2 | N, N'-SUBSTITUTED-1,3-DIAMINO-2-HYDROXYPROPANE DERIVATIVES | ELAN PHARMACEUTICALS, INC. (US) | 2003-05-15 | — | — | WO | disclosed |
| WO-2002044171-A1 | SUBSTITUTED DERIVATIVES OF AMINOFURAN-2-YL-ACETIC ACID AND AMINOTHIEN-2-YL-ACETIC ACID AND THE USE THEREOF FOR TREATING MIGRAINES AND PAIN | Grünenthal GmbH (DE) | 2002-06-06 | — | — | WO | disclosed |
| EP-1189643-A1 | OPHTHALMIC MOLDING | Novartis AG (CH) | 2002-03-27 | — | — | EP | disclosed |
| EP-1084428-A1 | ORGANIC ARTICLES | Novartis AG (CH) | 2001-03-21 | — | — | EP | disclosed |
| WO-2001002032-A1 | OPHTHALMIC MOLDING | NOVARTIS AG (CH) | 2001-01-11 | — | — | WO | disclosed |
| WO-1999057581-A1 | ORGANIC ARTICLES | NOVARTIS AG (CH) | 1999-11-11 | — | — | WO | disclosed |